Education
About Us
Working with TipRanks
Follow Us
Biotron Limited (AU:BIT)
ASX:BIT
Total Valuation
Biotron has a market cap or net worth of $6.64M. The enterprise value is AU$929.61K.
Market Cap$6.64M
Enterprise ValueAU$929.61K
Share Statistics
Biotron has 1,327,245,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,327,245,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biotron ’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is 288.05%.
Return on Equity (ROE)-0.58
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)288.05%
Return on Capital Employed (ROCE)-0.61
Revenue Per Employee453.41K
Profits Per Employee-79.64K
Employee Count4
Asset Turnover1.85
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biotron is ―. Biotron ’s PEG ratio is 0.07.
PE Ratio―
PS Ratio1.10
PB Ratio3.63
Price to Fair Value3.63
Price to FCF-3.52
Price to Operating Cash Flow16.43
PEG Ratio0.07
Income Statement
In the last 12 months, Biotron had revenue of 1.81M and earned -318.57K in profits. Earnings per share was 0.00.
Revenue1.81M
Gross Profit1.81M
Operating Income-338.75K
Pretax Income-318.57K
Net Income-318.57K
EBITDA-333.81K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -565.80K and capital expenditures -3.07K, giving a free cash flow of -568.87K billion.
Operating Cash Flow-565.80K
Free Cash Flow-568.87K
Free Cash Flow per Share>-0.01
Dividends & Yields
Biotron pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change-52.17%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)1.60M
Important Dates
Biotron upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Biotron as a current ratio of 2.23, with Debt / Equity ratio of 0.00%
Current Ratio2.23
Quick Ratio2.23
Debt to Market Cap0.00
Net Debt to EBITDA2.79
Interest Coverage Ratio-23.16
Taxes
In the past 12 months, Biotron has paid -1.81M in taxes.
Income Tax-1.81M
Effective Tax Rate5.69
Enterprise Valuation
Biotron EV to EBITDA ratio is -3.21, with an EV/FCF ratio of -1.88.
EV to Sales0.59
EV to EBITDA-3.21
EV to Free Cash Flow-1.88
EV to Operating Cash Flow-1.89
Balance Sheet
Biotron has $931.68K in cash and marketable securities with $0.00 in debt, giving a net cash position of $931.68K billion.
Cash & Marketable Securities$931.68K
Total Debt$0.00
Net Cash$931.68K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 98.96%, with operating margin of -18.68%, and net profit margin of -17.57%.
Gross Margin98.96%
Operating Margin-18.68%
Pretax Margin-17.57%
Net Profit Margin-17.57%
EBITDA Margin-18.41%
EBIT Margin-18.68%
Analyst Forecast
The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast87.88%